Presented by Michael Stevens (CEO)
Hosted by Travis Rodgers
Strictly limited to 20 principal investor seats.
Serious capital intent and accredited investors only.
LOCATION: Flemmings, 20 S 400 W, Salt Lake City, UT 84101
DATE: October 15, 2026
Strictly Curated · Private Deal Room · Direct Principal Access
A private, high-table gathering structured to deliver strategic market insights, gourmet culinary service, and direct executive access.
Strict Delegation Limit
Attendance is capped at 20 accredited investors.
Private welcome - introductions among founding investors.
Multi-course gourmet dining in quiet private dining room.
A private 30-minute operational presentation detailing market expansion metrics, clinical advantages, and growth roadmap.
Term evaluation, and private syndicate commitment discussion.
Formal conclusion of the dinner with digital distribution of data room access.
Principal investors, family offices, venture capital, and strategic dental investors
Written checks / signed commitments encouraged.
Introducing Lumos 3DX™ by Valkyrie BioScience — advanced Tomosynthesis technology, powered by Intelligent Imaging ™, delivering real-time clinical clarity.
Advanced technology with Tomosynthesis + Intelligent Imaging™
enhanced pathology visualization
Lightweight, mobile design
Seamless integration with existing workflows
Cloud based
Lumos 3DX by Valkyrie BioScience is a high-resolution dental imaging system that brings advanced diagnostics directly to the point of care. With a mobile, cloud-connected design and an intuitive interface, Lumos 3DX helps dental teams work faster, communicate more clearly, and treat with greater confidence.